RANI THERAPEUTICS HOLDINGS INC. - CLASS A COMMON

Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update

10 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at the Stifel Healthcare Conference

09 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update

24 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock

11 Aug 2022 23:47:30 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock

10 Aug 2022 17:28:34 By Nasdaq GlobeNewswire

Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update

10 Aug 2022 16:28:17 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis

10 Aug 2022 16:23:29 By Nasdaq GlobeNewswire

Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development

08 Aug 2022 08:30:00 By Nasdaq GlobeNewswire

Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update

11 May 2022 16:05:01 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at Upcoming Investor Conferences

03 May 2022 16:05:01 By Nasdaq GlobeNewswire

Rani Therapeutics’ RaniPill™ Capsule Named Winner in the Health Category of Fast Company’s 2022 World Changing Ideas Awards

03 May 2022 07:00:02 By Nasdaq GlobeNewswire

Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

07 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update

29 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022

23 Mar 2022 20:38:02 By Nasdaq GlobeNewswire

Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis

23 Mar 2022 08:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Unveils High-Capacity RaniPill™ Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results

23 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

Rani Therapeutics Appoints Lisa Rometty to Board of Directors

07 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update

15 Nov 2021 19:31:25 By Nasdaq GlobeNewswire

Rani Therapeutics Appoints Lyn Baranowski to Board of Directors

12 Nov 2021 16:05:00 By Nasdaq GlobeNewswire